story of the week
Prevalence of ESR1 Mutations in Cell-Free DNA Associated With Worse Outcomes in Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial
JAMA Oncol 2016 Aug 11;[EPub Ahead of Print], S Chandarlapaty, D Chen, W He, P Sung, A Samoila, D You, T Bhatt, P Patel, M Voi, M Gnant, G Hortobagyi, J Baselga, ME MoynahanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.